Ardelyx, Inc.
Ardelyx, Inc., a biopharmaceutical company headquartered in the United States, is dedicated to developing innovative therapies for patients with gastrointestinal and renal diseases. Founded in 2007, Ardelyx has made significant strides in the industry, particularly with its focus on unique mechanisms of action that address unmet medical needs. The company’s flagship product, tenapanor, is designed to treat conditions such as irritable bowel syndrome with constipation (IBS-C) and hyperphosphataemia in patients with chronic kidney disease. Ardelyx's commitment to scientific excellence and patient-centric solutions has positioned it as a notable player in the biopharmaceutical landscape. With a robust pipeline and a focus on advancing healthcare, Ardelyx continues to make impactful contributions to the industry.
DitchCarbon Score
How does Ardelyx, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ardelyx, Inc.'s score of 18 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ardelyx, Inc.'s reported carbon emissions
Ardelyx, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor do they have specified reduction targets or climate pledges. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability initiatives. However, the absence of data may indicate an opportunity for Ardelyx to enhance transparency and set measurable climate goals in line with industry standards. As the focus on corporate climate responsibility grows, it will be essential for Ardelyx to establish and communicate their carbon reduction strategies to align with global sustainability efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ardelyx, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
